HCA Holdings, Inc. (NYSE:HCA) has received an average rating of “Buy” from the twenty-six research firms that are covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and nineteen have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $90.33.

Several equities analysts have recently commented on HCA shares. ValuEngine cut shares of HCA from a “buy” rating to a “hold” rating in a report on Thursday, September 7th. KeyCorp reaffirmed an “overweight” rating and issued a $90.00 price objective (down previously from $95.00) on shares of HCA in a research note on Thursday, October 19th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $90.00 price objective on shares of HCA in a research note on Tuesday, October 31st. Zacks Investment Research lowered shares of HCA from a “hold” rating to a “sell” rating in a research note on Tuesday, October 17th. Finally, Raymond James Financial lowered shares of HCA from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, October 18th.

HCA (HCA) traded up $2.31 during trading on Monday, hitting $88.46. 3,810,800 shares of the stock traded hands, compared to its average volume of 2,302,826. The company has a debt-to-equity ratio of -6.46, a quick ratio of 1.41 and a current ratio of 1.68. HCA has a fifty-two week low of $71.18 and a fifty-two week high of $91.03. The stock has a market cap of $31,319.53, a PE ratio of 13.42, a P/E/G ratio of 1.30 and a beta of 0.56.

HCA (NYSE:HCA) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $1.21 EPS for the quarter, meeting the consensus estimate of $1.21. HCA had a net margin of 6.13% and a negative return on equity of 47.16%. The business had revenue of $10.70 billion for the quarter, compared to analysts’ expectations of $10.70 billion. During the same period in the previous year, the company posted $1.45 EPS. HCA’s revenue was up 4.1% on a year-over-year basis. research analysts anticipate that HCA will post 6.56 earnings per share for the current year.

In other news, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $78.00, for a total transaction of $167,700.00. Following the completion of the transaction, the insider now owns 12,476 shares of the company’s stock, valued at $973,128. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Victor L. Campbell sold 8,000 shares of the company’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $78.00, for a total transaction of $624,000.00. Following the transaction, the senior vice president now directly owns 127,275 shares of the company’s stock, valued at approximately $9,927,450. The disclosure for this sale can be found here. In the last three months, insiders have sold 20,300 shares of company stock valued at $1,565,960. Company insiders own 2.90% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. lifted its holdings in HCA by 14.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after buying an additional 143 shares during the period. Bronfman E.L. Rothschild L.P. raised its holdings in HCA by 35.1% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock worth $107,000 after purchasing an additional 320 shares during the period. Atlantic Trust LLC acquired a new stake in HCA in the second quarter worth $118,000. Acrospire Investment Management LLC raised its holdings in HCA by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock worth $140,000 after purchasing an additional 200 shares during the period. Finally, BB&T Investment Services Inc. acquired a new stake in HCA in the second quarter worth $141,000. 75.35% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “HCA Holdings, Inc. (HCA) Receives Consensus Recommendation of “Buy” from Analysts” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/hca-holdings-inc-hca-receives-consensus-recommendation-of-buy-from-analysts/1771553.html.

HCA Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA (NYSE:HCA)

Receive News & Ratings for HCA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA and related companies with MarketBeat.com's FREE daily email newsletter.